Suppr超能文献

一氧化氮信号转导与心血管系统调控:最新进展。

Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances.

机构信息

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (M.C., E.W., J.O.L.); and Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden (E.W.)

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (M.C., E.W., J.O.L.); and Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden (E.W.).

出版信息

Pharmacol Rev. 2024 Oct 16;76(6):1038-1062. doi: 10.1124/pharmrev.124.001060.

Abstract

Nitric oxide (NO) from endothelial NO synthase importantly contributes to vascular homeostasis. Reduced NO production or increased scavenging during disease conditions with oxidative stress contribute to endothelial dysfunction and NO deficiency. In addition to the classical enzymatic NO synthases (NOS) system, NO can also be generated via the nitrate-nitrite-NO pathway. Dietary and pharmacological approaches aimed at increasing NO bioactivity, especially in the cardiovascular system, have been the focus of much research since the discovery of this small gaseous signaling molecule. Despite wide appreciation of the biological role of NOS/NO signaling, questions still remain about the chemical nature of NOS-derived bioactivity. Recent studies show that NO-like bioactivity can be efficiently transduced by mobile NO-ferroheme species, which can transfer between proteins, partition into a hydrophobic phase, and directly activate the soluble guanylyl cyclase-cGMP-protein kinase G pathway without intermediacy of free NO. Moreover, interaction between red blood cells and the endothelium in the regulation of vascular NO homeostasis have gained much attention, especially in conditions with cardiometabolic disease. In this review we discuss both classical and nonclassical pathways for NO generation in the cardiovascular system and how these can be modulated for therapeutic purposes. SIGNIFICANCE STATEMENT: After four decades of intensive research, questions persist about the transduction and control of nitric oxide (NO) synthase bioactivity. Here we discuss NO signaling in cardiovascular health and disease, highlighting new findings, such as the important role of red blood cells in cardiovascular NO homeostasis. Nonclassical signaling modes, like the nitrate-nitrite-NO pathway, and therapeutic opportunities related to the NO system are discussed. Existing and potential pharmacological treatments/strategies, as well as dietary components influencing NO generation and signaling are covered.

摘要

一氧化氮(NO)来源于内皮型一氧化氮合酶,对血管稳态至关重要。在氧化应激引起的疾病状态下,NO 产生减少或清除增加,导致内皮功能障碍和 NO 缺乏。除了经典的酶型一氧化氮合酶(NOS)系统外,NO 还可以通过硝酸盐-亚硝酸盐-NO 途径生成。自发现这种小分子气体信号分子以来,旨在提高 NO 生物活性(尤其是在心血管系统中)的饮食和药理学方法一直是研究的重点。尽管人们广泛认识到 NOS/NO 信号转导的生物学作用,但关于 NOS 衍生生物活性的化学性质仍存在疑问。最近的研究表明,NO 样生物活性可以被可移动的 NO-亚铁血红素物种有效地转导,这些物种可以在蛋白质之间转移、分配到疏水区,并直接激活可溶性鸟苷酸环化酶-cGMP-蛋白激酶 G 途径,而无需游离 NO 的中介。此外,红细胞与内皮细胞在调节血管 NO 稳态方面的相互作用引起了广泛关注,尤其是在伴有心脏代谢疾病的情况下。在这篇综述中,我们讨论了心血管系统中 NO 生成的经典和非经典途径,以及如何为治疗目的调节这些途径。意义声明:经过四十年的深入研究,关于一氧化氮(NO)合酶生物活性的转导和控制仍存在疑问。在这里,我们讨论了心血管健康和疾病中的 NO 信号转导,强调了新的发现,例如红细胞在心血管 NO 稳态中的重要作用。讨论了非经典信号模式,如硝酸盐-亚硝酸盐-NO 途径,以及与 NO 系统相关的治疗机会。涵盖了现有的和潜在的药理学治疗/策略,以及影响 NO 生成和信号转导的饮食成分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验